Tularemia is a zoonosis, a disease of animals transmissible to humans, and is caused by the facultative intracellular bacterium Francisella tularensis. F. tularensis is considered a potential agent of biological warfare and bioterrorism and as such has been rated among the top 6 category A agents. Formerly, F. tularensis was included among agents developed and used by state‐sponsored bioweapons programs. In fact, F. tularensis is one of the most infectious pathogenic bacteria known, requiring inoculation or inhalation of as few as 10 organisms to cause human infection. At present there are four recognized subspecies of F. tularensis: tularensis, holarctica, mediasiatica, and novicida. The natural reservoirs of F. tularensis still await complete delineation. Little is known about the virulence mechanisms of F. tularensis. In a bioterrorism scenario, respiratory tularemia (acquired through inhalation) is judged to be the greatest threat. Natural outbreaks of human respiratory type A or type B tularemia have repeatedly been recorded in farmers and landscape workers illustrating the potential of effective F. tularensis transmission by dry aerosols. The clinical expression of tularemia largely depends on the route of entrance of the infectious agent and the prognosis in tularemia is highly dependent on the causative subspecies of F. tularensis. There is currently no licensed and widely available tularemia vaccine. Tularemia warrants antibiotic treatment and is not transmitted from person to person. Currently, there is a reawakened interest in tularemia and a rapid development of new diagnostics, prophylactics and therapies.